OK HB1576

Oklahoma Health Care Authority must provide Medicaid coverage for rapid whole genome sequencing as a separately payable service for beneficiaries under 21 years of age who have complex or acute illnesses of unknown cause and are receiving care in a hospital ICU or high acuity unit

Rapid whole genome sequencing must return preliminary positive results within 7 days and final results within 15-21 days, and includes patient-only testing or duo/trio testing with biological parents

Coverage is subject to medical necessity criteria including conditions such as congenital anomalies, refractory seizures, abnormal cardiac testing, metabolic disorders, and family genetic history suggesting a genetic etiology

Genetic data generated from testing is protected under HIPAA and may only be used for scientific research with express patient or guardian consent, with the right to rescind consent and have data expunged at any time

Effective date is July 1, 2025, with an emergency clause allowing immediate effect upon passage and approval